Your browser doesn't support javascript.
loading
Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study.
Straus, David J; Dlugosz-Danecka, Monika; Alekseev, Sergey; Illés, Árpád; Picardi, Marco; Lech-Maranda, Ewa; Feldman, Tatyana; Smolewski, Piotr; Savage, Kerry J; Bartlett, Nancy L; Walewski, Jan; Ramchandren, Radhakrishnan; Zinzani, Pier Luigi; Hutchings, Martin; Connors, Joseph M; Radford, John; Munoz, Javier; Kim, Won Seog; Advani, Ranjana; Ansell, Stephen M; Younes, Anas; Miao, Harry; Liu, Rachael; Fenton, Keenan; Forero-Torres, Andres; Gallamini, Andrea.
Afiliación
  • Straus DJ; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Dlugosz-Danecka M; Department of Hematology, Jagiellonian University Medical College, Krakow, Poland.
  • Alekseev S; N. N. Petrov Scientific Research Institute of Oncology, St. Petersburg, Russian Federation.
  • Illés Á; Department of Hematology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Picardi M; Department of Advanced Biomedical Science, Federico II University Hospital, Naples, Italy.
  • Lech-Maranda E; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
  • Feldman T; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ.
  • Smolewski P; Department of Experimental Hematology, Medical University of Lodz, Lodz, Poland.
  • Savage KJ; Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Bartlett NL; Department of Medical Oncology, BC Cancer Centre for Lymphoid Cancer, Vancouver, BC, Canada.
  • Walewski J; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
  • Ramchandren R; Department of Lymphoid Malignancy, The Maria Sklodowska-Curie Memorial Institute and Oncology Center, Warsaw, Poland.
  • Zinzani PL; Department of Medicine, Graduate School of Medicine, The University of Tennessee, Knoxville, TN.
  • Hutchings M; Institute of Hematology Seragnoli, University of Bologna, Bologna, Italy.
  • Connors JM; Department of Hematology, Finsen Centre, National Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
  • Radford J; Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Munoz J; Department of Medical Oncology, BC Cancer Centre for Lymphoid Cancer, Vancouver, BC, Canada.
  • Kim WS; Department of Medical Oncology, University of Manchester, Manchester, United Kingdom.
  • Advani R; Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Ansell SM; Department of Lymphoma/Myeloma, Banner MD Anderson Cancer Center, Gilbert, AZ.
  • Younes A; Department of Medicine, Samsung Medical Center, Sungkyunkwan University, Seoul, South Korea.
  • Miao H; Department of Medicine/Oncology, Stanford Cancer Institute, Stanford, CA.
  • Liu R; Department of Internal Medicine, Mayo Clinic, Rochester, MN.
  • Fenton K; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Forero-Torres A; Millennium Pharmaceuticals, Inc, Cambridge, MA, a wholly owned subsidiary of Takeda Pharmaceuticals Company Limited.
  • Gallamini A; Millennium Pharmaceuticals, Inc, Cambridge, MA, a wholly owned subsidiary of Takeda Pharmaceuticals Company Limited.
Blood ; 135(10): 735-742, 2020 03 05.
Article en En | MEDLINE | ID: mdl-31945149
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Brentuximab Vedotina Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Brentuximab Vedotina Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2020 Tipo del documento: Article